Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Bethesda, MD

240 studies for Lung Cancer are recruiting at 417 sites within 50 miles of Bethesda, Maryland, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Bethesda.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Bethesda

Showing the 50 nearest of 240 studies.
  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Walter Reed National Military Medical Center (Bethesda, MD); MedStar Georgetown University Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  2. A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

    NCT07144280

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Maryland Oncology Hematology, P.A. (Bethesda, MD); Maryland Oncology Hematology, P.A. (Silver Spring, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  3. Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    NCT07222566

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Maryland Oncology Hematology, P.A. (Bethesda, MD); Maryland Oncology Hematology, P.A. (Silver Spring, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  4. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (Bethesda, MD); Massive Bio SYNERGY-AI site (Silver Spring, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  5. GEMINI-NSCLC: NSCLC Biomarker Study

    NCT05236114

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The Center for Cancer and Blood Disorder (Bethesda, MD); Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  6. A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

    NCT06868277

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Bethesda, MD); Research Site (Silver Spring, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  7. Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

    NCT06350097

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Bethesda, MD); Research Site (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  8. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Walter Reed National Military Medical Center (Bethesda, MD); Inova Fair Oaks Hospital (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  9. A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

    NCT07218146

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: American Oncology Partners, PA - The Center for Cancer and Blood Disorders (Bethesda, MD); Maryland Oncology Hematology (Silver Spring, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  10. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

    NCT06692738

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Bethesda, MD); Research Site (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Walter Reed National Military Medical Center (Bethesda, MD); Saint Agnes Hospital - Baltimore - Hunt - PPDS (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Evaluation for NCI Surgery Branch Clinical Research Protocols

    NCT00001823

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Collection of Blood From Patients With Cancer

    NCT00034216

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

    NCT00242723

    • Observational
    • Ages 2 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

    NCT00451022

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

    NCT01441089

    • Observational
    • Ages 3 years and older
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

    NCT01950572

    • Observational
    • Ages 2 to 100 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

    NCT02133196

    • Phase 2
    • Ages 18 to 72 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

    NCT02146170

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

    NCT02682667

    • Observational
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

    NCT03412877

    • Phase 2
    • Ages 18 to 72 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

    NCT05592626

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: National Institutes of Health (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer

    NCT05777603

    • Phase 1
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

    NCT06066138

    • Phase 1
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

    NCT06171750

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: National Cancer Institute (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

    NCT06228066

    • Phase 2
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

    NCT06479811

    • Phase 1
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

    NCT06503146

    • Phase 2
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

    NCT06885697

    • Phase 1
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

    NCT06953089

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: USA11-0 (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

    NCT07509034

    • Phase 1
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente - Kensington Medical Center (Kensington, MD); Kaiser Permanente Tysons Corner Medical Center (McLean, VA)

    Distance to nearest recruiting site
    ~3 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  33. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Maryland Oncology Hematology P A (Silver Spring, MD); MedStar Georgetown University Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    ~4 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  34. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente Tysons Corner Medical Center (McLean, VA); Kaiser Permanente-Capitol Hill Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  35. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT06616584

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente Tysons Corner Medical Center (McLean, VA); Kaiser Permanente-Capitol Hill Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  36. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente Tysons Corner Medical Center (McLean, VA); Kaiser Permanente-Capitol Hill Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  37. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

    NCT06031688

    • Phase 2
    • Ages 18 Minutes and older
    • Sex: All

    Nearest sites: Kaiser Permanente Tysons Corner Medical Center (McLean, VA); Kaiser Permanente-Capitol Hill Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  38. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    NCT06500481

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Sibley Memorial Hospital (Washington D.C., DC); Inova Alexandria Hospital (Alexandria, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  39. Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

    NCT06712316

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MEDSTAR Washington Hospital Center (MedStar Health Research Institute) (Washington D.C., DC); MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH) (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  40. Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

    NCT04499053

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Georgetown Lombardi Comprehensive Cancer Center (Washington D.C., DC); Medstar Washington Hospital Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  41. Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    NCT06096844

    • Phase 3
    • Ages 70 years and older
    • Sex: All

    Nearest sites: George Washington University Medical Center (Washington D.C., DC); Sinai Hospital of Baltimore (Baltimore, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  42. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Sibley Memorial Hospital (Washington D.C., DC); USO - Virginia Cancer Specialists (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  43. Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

    NCT05098132

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Georgetown University (Washington D.C., DC); NEXT Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  44. A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

    NCT05498428

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital (Washington D.C., DC); Virginia Cancer Specialists (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  45. A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

    NCT06095505

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Georgetown Lombardi Cancer Center (Washington D.C., DC); Virginia Cancer Specialists Research Institute (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  46. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    NCT06287775

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MedStar Georgetown University Hospital (Washington D.C., DC); Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  47. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Sibley Memorial Hospital (Washington D.C., DC); Johns Hopkins Bayview Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  48. A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

    NCT04302025

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center) (Washington D.C., DC); Virginia Cancer Specialists (Fairfax) - USOR (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  49. A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies

    NCT05443126

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Georgetown University (Washington D.C., DC); Virginia Cancer Specialists (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  50. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Georgetown University Medical Center (Washington D.C., DC); Virginia Cancer Specialists (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.